“Today more than 33 thousand people received the first dose of the component - this is a component based on adenovirus of the 26th serotype.

And almost 32 thousand have already received both components.

That is, practically the enrollment in the clinical trial is over, "TASS quoted him as saying at a press conference.

Logunov noted that more than 1.6 million doses of the vaccine have entered the civilian circulation.

Earlier it was reported that studies of the Sputnik V coronavirus vaccine among children will take place during 2021.